share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director TILTON GLENN F

SEC announcement ·  May 8 06:31
Summary by Futu AI
Glenn F. Tilton, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the reporting person, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Tilton's direct holdings in AbbVie common stock increased to a total of 50,361 shares. Additionally, there is an indirect ownership of 350 shares held by Tilton's wife. The transaction reflects Tilton's growing stake in the company and may be of interest to investors monitoring insider activities.
Glenn F. Tilton, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the reporting person, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Tilton's direct holdings in AbbVie common stock increased to a total of 50,361 shares. Additionally, there is an indirect ownership of 350 shares held by Tilton's wife. The transaction reflects Tilton's growing stake in the company and may be of interest to investors monitoring insider activities.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.